DrugInformations.org

The American Psychiatric Association (APA) congratulates APA Distinguished Fellow Deborah Peel, M.D. on being named fourth on the list of the 100 Most Powerful People in Healthcare in the August Modern Healthcare. The list places Dr. Peel alongside Sister Carol Keehan, Governors Mitt Romney and Arnold Schwarzenegger, President Bush and Senator Hillary Clinton. With over 12,600 nominations and 265,000 votes cast, Dr. [click link for full article]

More: continued here

No Comments »

For years researchers in neurology have believed that people with Huntington’s disease have more children than the general population because of behavioral changes associated with the disease that lead to sexual promiscuity. In a new Tufts University study, three biologists have challenged that notion by suggesting that people with Huntington’s have more children because they are healthier — not more promiscuous — during their peak reproductive years. [click link for full article]

More: continued here

No Comments »

United Auto Workers President Ron Gettelfinger on Monday gave the signal for union members to begin their first national strike against General Motors in 37 years over issues of job security, not health care costs, the Detroit News reports. [click link for full article]

More: continued here

No Comments »

About a third of American adults take some type of multivitamin on a regular basis. In nearly every case, the goal is better health, even though there is no firm evidence to support this hope. The absence of benefit is one thing, but the presence of harm is another: A 2007 report in the Journal of the National Cancer Institute concluded that there was an increased prostate cancer risk among men using multivitamins, reports the October 2007 issue of Harvard Men’s Health Watch. [click link for full article]

More: continued here

No Comments »

Palatin Technologies, Inc. (Amex: PTN) announced positive results from an at home Phase 2 trial evaluating bremelanotide for the treatment of female sexual arousal disorder (FSAD). The objective of this exploratory study was to identify potential efficacy endpoints for future studies and to evaluate the safety of intranasal (IN) bremelanotide, relative to placebo and under the conditions of home use, for the treatment of FSAD in pre and postmenopausal women. [click link for full article]

More: continued here

No Comments »

Spectranetics Corporation (Nasdaq: SPNC) announced it has enrolled the first patient in the PATENT trial utilizing the Company’s TURBO elite(TM) laser catheters in combination with the recently FDA cleared TURBO-Booster(TM). The PATENT trial is a prospective registry of 100 patients at up to 10 sites in Germany. The trial will assess patency as measured by duplex ultrasound at various intervals up to 12 months following the procedure. [click link for full article]

More: continued here

No Comments »

Researchers in Australia have shown that positron emission tomography (PET) that uses a radioactive sugar molecule is more useful than mammography and ultrasound in predicting a breast tumour’s response to chemotherapy and, therefore, the patient’s ultimate likelihood of survival. [click link for full article]

More: continued here

No Comments »

ALL frontline healthcare workers should to be given a free personal attack alarm to help protect them from violent attacks, Welsh doctors’ leaders said. BMA Cymru Wales’ continued call for tough action against violence against NHS staff follows an announcement by Secretary of State for Health, Alan Johnson MP*, that NHS Trusts in England will receive an additional £97m to protect workers’. [click link for full article]

More: continued here

No Comments »

Pharmaceutical company Warner Chilcott on Monday announced it has filed a lawsuit against Barr Laboratories in response to Barr’s FDA application for a generic version of Warner’s chewable oral contraceptive Femcon Fe, the AP/CNNMoney. [click link for full article]

More: continued here

No Comments »

The Medical University of South Carolina (MUSC) will lead a $6 million study to determine the best techniques for diagnosing and treating sphincter of Oddi dysfunction (SOD), a painful condition that causes narrowing or spasm of the muscle that controls the flow of bile and pancreatic juice into the small intestine. [click link for full article]

More: continued here

No Comments »